The disconnect stems from how GLP-1 medications are traditionally prescribed and supported
In Australia, most peptides require a prescription
Method The PubMed and Web of Science online databases were searched to identify relevant studies published in the English language using the terms PraderWilli syndrome with glucose, insulin, diabetes mellitus, fat, adipo*, ghrelin, oxytocin, irisin or autonomic nervous system
Moreover, treatment with EMDB-1 extended half-life of GLP-2 (Salaga et al
According to Celltrion, Steqeyma was approved based in part on the findings of a Phase III study in plaque psoriasis, which demonstrated that the biosimilar had no clinically meaningful differences versus Stelara in terms of efficacy or safety